Author

C. O'Leary

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:bacteria (other)· 1 Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:imaging· 1

Frequent Co-Authors

A. A. Chang· 1 shared A. B. Molofsky· 1 shared A. Holt· 1 shared A. L. Gan· 1 shared A. N. Mattis· 1 shared A.-L. Barabasi· 1 shared C. J. Donahue· 1 shared C. Martin· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. A. Chang

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Group 2 innate lymphoid cells constrain type 3/17 lymphocytes in shared stromal niches to restrict liver fibrosis

J. Sbierski-Kind, K. M. Cautivo, J. Wagner, M. W. Dahlgren, J. Nilsson, M. Krasilnikov, N. M. Mroz, C. O. Lizama, A. L. Gan, P. R. Matatia, M. T. Taruselli, A. A. Chang, S. Caryotakis, C. O'Leary, M. Kotas, , A. B. Molofsky

The paper investigates the role of IL-5+ lymphocytes and type 3/17 lymphocytes in liver fibrosis, showing their spatial relationship and cross-regulation in fibroblast niches.

bioRxiv · Apr 26, 2023 · PreprintImmunology

Identification of druggable host targets needed for SARS-CoV-2 infection by combined pharmacological evaluation and cellular network directed prioritization both in vitro and in vivo.

J. Patten, P. T. Keiser, D. M. Gysi, G. Menichetti, H. Mori, C. J. Donahue, X. Gan, I. F. do Valle, K. Geoghegan-Barek, M. Anantpadma, R. Boytz, J. L. Berrigan, S. Hulsey-Stubbs, K. T. Ayazika, C. O'Leary, , R. A. Davey

The paper identifies 389 small molecules and 813 host targets that inhibit SARS-CoV-2 infection through in vitro and in vivo testing, using computational integration of drug activity and cellular networks.

bioRxiv · Apr 20, 2021 · PreprintMicrobiology

Phage-encoded cationic antimicrobial peptide used for outer membrane disruption in lysis

A. Holt, J. Cahill, J. Ramsey, C. O'Leary, R. Moreland, C. Martin, D. T. Galbadage, R. Sharan, P. Sule, K. Bettridge, J. Xiao, J. Cirillo, R. Young

This study identifies a phage-encoded cationic antimicrobial peptide, Gp28, that disrupts bacterial outer membranes during lysis, functioning similarly to human antimicrobial peptides like LL-37.

bioRxiv · Jan 8, 2019 · PreprintMicrobiology